Li, Chunliang

A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition

Traxler, E. A., Yao, Y., Wang, Y.-D., Woodard, K. J., Kurita, R., Nakamura, Y., Hughes, J. R., Hardison, R. C., Blobel, G. A., Li, C., et al. (2016) · Nature Medicine

Hemoglobinopathies and Related DisordersCRISPR and Genetic Engineering

Cited by 366

Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X

Liu, Y., Li, C., Shen, S., Chen, X., Szlachta, K., Edmonson, M. N., Shao, Y., Ma, X., Hyle, J., Wright, S., et al. (2020) · Nature Genetics

Cancer Genomics and DiagnosticsGenomics and Chromatin Dynamics

Cited by 64

Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma

Yao, T., Zhang, Z., Li, Q., Huang, R., Hong, Y., Li, C., Zhang, F., Huang, Y., Fang, Y., Cao, Q., et al. (2023) · Cancer Immunology Research

Ocular Oncology and TreatmentsCancer Immunotherapy and Biomarkers

Cited by 22